HCV: MyOme Raises $23M in Series B Funding

MyOme, a Menlo Park, CA-based clinical whole genome platform analysis company, raised $23m in Series B financing. The round, which brought the total raised to over $36M, was led by Healthcare Venture Partners. The company intends to use the funds to begin commercialization of its clinical whole genome analysis platform technology and clinical reports to health systems. Led [...]The post MyOme Raises $23M in Series B Funding appeared first on FinSMEs.